A comprehensive genetic study, the largest of its kind analyzing common variants in Alzheimer's disease, examined data from over 2.8 million individuals across multiple ancestry groups.Researchers identified 127 genetic regions associated with Alzheimer's risk, including 48 new ones not previously reported.The study incorporated data from 109,479 confirmed Alzheimer's cases and additional proxy cases, drawing from 30 different cohorts.

Key findings highlight connections to brain immune cells known as microglia, neuronal functions, immune activity, fat metabolism, and amyloid beta processing pathways.

While many existing treatments target amyloid plaques, these new genetic signals point to broader biological mechanisms that could inform future therapies.The analysis strengthened links to microglia's role in clearing debris and responding to brain changes.

It also detected risk signals in various neuron types, suggesting inherited factors influence both brain defense responses and neuronal vulnerability.Among the new regions, 17 genes showed potential interactions with existing approved drugs, offering promising avenues for drug development research.Genetic risk prediction improved, with individuals in the top 10% of risk scores showing substantially higher prevalence in certain populations.However, the study notes limitations due to the majority of data coming from European ancestry participants, reducing precision for diverse groups.

This research expands understanding of Alzheimer's complexity beyond traditional plaque and tangle pathology, providing new targets for investigation into prevention and treatment strategies.